NDC 51072-020-02 - Equisul-SDT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51072-020
- Requested NDC
- 51072-020-02
- Package NDCs from labels
- 51072-020-00, 51072-020-01, 51072-020-02, 51072-020-03
- Manufacturer
- Aurora Pharmaceutical, Inc.
- Effective date
- 2025-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EQUISUL-SDT ® (Sulfadiazine/Trimethoprim) Oral Suspension | Aurora Pharmaceutical, Inc. | 2025-06-16 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51072-020-00 | Equisul-SDT | 900 mL in 1 BOTTLE | SUSPENSION | 900 | 15 | |
| 51072-020-01 | Equisul-SDT | 135 mL in 1 BOTTLE | SUSPENSION | 135 | 15 | |
| 51072-020-02 | Equisul-SDT | 560 mL in 1 BOTTLE | SUSPENSION | 560 | 15 | |
| 51072-020-03 | Equisul-SDT | 280 mL in 1 BOTTLE | SUSPENSION | 280 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| SULFADIAZINE | ACTIVE INGREDIENT | 0N7609K889 | EQUISUL-SDT (SULFADIAZINE AND TRIMETHOPRIM) SUSPENSION [AURORA PHARMACEUTICAL LLC] | 3 | |
| TRIMETHOPRIM | ACTIVE INGREDIENT | AN164J8Y0X | EQUISUL-SDT (SULFADIAZINE AND TRIMETHOPRIM) SUSPENSION [AURORA PHARMACEUTICAL LLC] | 3 | |
| SULFADIAZINE | ACTIVE MOIETY | 0N7609K889 | EQUISUL-SDT (SULFADIAZINE AND TRIMETHOPRIM) SUSPENSION [AURORA PHARMACEUTICAL LLC] | 3 | |
| TRIMETHOPRIM | ACTIVE MOIETY | AN164J8Y0X | EQUISUL-SDT (SULFADIAZINE AND TRIMETHOPRIM) SUSPENSION [AURORA PHARMACEUTICAL LLC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| polymyxin b sulfate and trimethoprim sulfate | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | REMEDYREPACK INC. | c68818b2-d849-41d2-be07-731244afbbac | 2026-09-09 | Warnings, Adverse reactions | AN164J8Y0X |
| SULFATRIM | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Preferred Pharmaceuticals, Inc. | cd4932ce-0856-4e99-8baf-70afce1d7ffd | 2026-09-02 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Preferred Pharmaceuticals Inc. | d60c218c-6529-4944-af0b-a9dc720f32e9 | 2026-09-02 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Preferred Pharmaceuticals Inc. | c6171b62-835c-465e-905e-97f70438186e | 2026-09-02 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | ATLANTIC BIOLOGICALS CORP. | acc3df02-1e99-46e6-8a31-9b26261c6daa | 2026-08-25 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | REMEDYREPACK INC. | ce44959b-4bfe-4ba9-9fc2-7f9d4663d542 | 2026-08-10 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Cardinal Health 107, LLC | 5dc03027-cdaf-461f-87fd-630d382fc723 | 2026-08-07 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | REMEDYREPACK INC. | ec2e335c-3357-40d8-9615-a09fc40ce5f4 | 2026-08-07 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | REMEDYREPACK INC. | c45ac3a4-d397-486e-abd1-349916543068 | 2026-07-27 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Cardinal Health 107, LLC | 08500fcb-dbec-4ac2-91c3-189d27907ec0 | 2026-07-17 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Unit Dose Solutions, Inc. | 562e2547-db2d-e2d2-e063-6294a90a1f5d | 2026-07-09 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | St. Mary's Medical Park Pharmacy | e3a49508-0ebe-1334-e053-2a95a90ae173 | 2026-06-11 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Coupler LLC | 518cc045-a12b-f08f-e063-6394a90acb0c | 2026-05-11 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | ANI Pharmaceuticals, Inc. | 5ff03694-787a-409d-a95e-8422aa27499c | 2026-04-06 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Amneal Pharmaceuticals LLC | f0e73842-6002-43c2-97fc-0cadc1bf6346 | 2026-04-02 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 69af86b4-9c9f-4a70-b448-97b36698f3cd | 2026-03-26 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | AvPAK | 29df8839-3dfa-0b2b-c5a3-906db6997b3b | 2026-03-24 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 75b9d194-b960-4943-bedc-96e3d65c4da9 | 2026-03-03 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Chartwell Governmental & Specialty RX, LLC. | 2a5173ba-047d-4a80-81fb-7154265ae3d1 | 2026-02-24 | Warnings, Adverse reactions | AN164J8Y0X |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | AvKARE | 9f130443-c8e7-9122-8f27-f72f07f3f29e | 2026-02-10 | Warnings, Adverse reactions | AN164J8Y0X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.